Skip to main content
SpringerLink
Log in

Effect of Poloxamer 188 on Collateral Blood Flow, Myocardial Infarct Size, and Left Ventricular Function in a Canine Model of Prolonged (3-Hour) Coronary Occlusion and Reperfusion

  • Published:
Journal of Thrombosis and Thrombolysis Aims and scope Submit manuscript

Abstract

Poloxamer 188 is a surfactant with hemorheological, antithrombotic, and neutrophil-inhibitory properties. This agent has been demonstrated to reduce infarct size and to improve left ventricular function in animal models of myocardial infarction and reperfusion, and recently in a randomized trial of patients receiving thrombolytic therapy for acute myocardial infarction. In addition to reducing reperfusion injury, poloxamer 188 might be beneficial by increasing collateral blood flow. The purpose of this study was to determine the effect of poloxamer 188 on collateral blood flow, myocardial infarct size, and left ventricular function in a canine model of prolonged (3 hours) coronary occlusion and reperfusion. Closed-chest dogs (n = 21) underwent a 3-hour coronary occlusion and 3 hours of reperfusion. At 1 hour of occlusion, dogs received poloxamer 188, 75 mg/kg IV bolus, followed by 150 mg/kg/h IV for the final 2 hours of coronary occlusion and throughout reperfusion, or a saline placebo. Regional myocardial blood flow was measured using colored microspheres. Myocardial infarct size and area at risk were determined by postmortem histochemical staining. Compared with controls, poloxamer 188–treated dogs showed no significant increase in collateral blood flow during the final 2 hours of a 3-hour coronary artery occlusion. In addition, poloxamer 188 treatment had no beneficial effect on infarct size or left ventricular function in this model. Increased collateral blood flow is unlikely to be a beneficial mechanism of poloxamer 188 in myocardial infarction. These data also question the benefit of this agent to reduce reperfusion injury in the setting of more prolonged (3-hour) coronary occlusion.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Carter C, Fisher TC, Hamai H, et al. Haemorheological effects of a nonionic copolymer surfactant (poloxamer 188). Clin Hemorheol 1992;12:109–120.

    Google Scholar 

  2. Hunter RL, Papadea C, Gallagher CJ, Finlayson DC, Check IJ. Increased whole blood viscosity during coronary artery bypass surgery: Studies to evaluate the effects of soluble fibrin and poloxamer 188. Thromb Haemostas 1990;63:6–12.

    Google Scholar 

  3. Grover FL, Kahn RS, Heron MW, Paton BC. A nonionic surfactant and blood viscosity: Experimental observations. Arch Surg 1973;106:307–310.

    Google Scholar 

  4. Gaehtgens P, Benner KU. Disaggregation of human red blood cells by various surface-active agents as related to changes of cell shape and hemolysis. Acta Haematol 1975;53:82–89.

    Google Scholar 

  5. Smith CM, Hebbel RP, Tukey DP, Clawson CC, White JG, Vercellotti GM. Pluronic F-68 reduces the endothelial adherance and improves the rheology of liganded sickle erythrocytes. Blood 1987;69:1631–1636.

    Google Scholar 

  6. Schaer GL, Hursey TL, Abrahams SL, et al. Reduction in reperfusion-induced myocardial necrosis in dogs by RheothRx injection (poloxamer 188, N.F.), a hemorheological agent that alters neutrophil function. Circulation 1994;90:2964–2975.

    Google Scholar 

  7. Schaer GL, Moy JN, Hursey TL, Rajwani KS, Thota V, Parrillo JE. Neutrophil function is altered by RheothRx injection (poloxamer 188), a hemorheologic agent shown to reduce reperfusion injury (abstr). J Am Coll Cardiol 1994;23:198.

    Google Scholar 

  8. Justicz AG, Farnsworth WV, Soberman MS, et al. Reduction of myocardial infarct size by poloxamer 188 and mannitol in a canine model. Am Heart J 1991;122:671–680.

    Google Scholar 

  9. Schaer GL, Spaccavento LJ, Browne KF, et al. Beneficial effects of RheothRx Injection in patients receiving thrombolytic therapy for aute myocardial infarction. Circulation 1996;94:298–307.

    Google Scholar 

  10. O'Keefe JH Jr., Grines CL, DeWood MA, et al. Poloxamer-188 as an adjunct to primary percutaneous transluminal coronary angioplasty for acute myocardial infarction. Am J Cardiol 1996;78:747–750.

    Google Scholar 

  11. Weaver WD. Randomized, placebo controlled trial of RheothRx (poloxamer 188) injection in patients with suspected acute myocardial infarction (AMI) (abstr). Circulation 1995;92:I24.

    Google Scholar 

  12. Collaborative Organization for RheothRx Evaluation (CORE). Effects of RheothRx on mortality, morbidity, left ventricular function, and infarct size in patients with acute myocardial infarction. Circulation 1997;96:192–201.

    Google Scholar 

  13. Hansen PR. Role of neutrophils in myocardial ischemia and reperfusion. Circulation 1995;91:1872–1885.

    Google Scholar 

  14. Entman ML, Michael L, Rossen RD, et al. Inflammation in the course of early myocardial ischemia. FASEB J 1991;5:2529–2537.

    Google Scholar 

  15. Kloner RA. Does reperfusion injury exist in humans? J Am Coll Cardiol 1993;21:537–545.

    Google Scholar 

  16. Carr ME Jr., Powers PL, Jones MR. Effects of poloxamer 188 on the assembly, structure, and dissolution of fibrin clots. Thromb Haemost 1991;66:565–568.

    Google Scholar 

  17. Hunter RL, Bennett B, Check IJ. The effect of poloxamer 188 on the rate of in vitro thrombolysis mediated by t-PA and streptokinase. Fibrinolysis 1990;4:117–123.

    Google Scholar 

  18. Reimer KA, Jennings RB, Cobb FR, et al. Animal models for protecting ischemic myocardium: Results of the NHLBI cooperative study. Circ Res 1985;56:651–665.

    Google Scholar 

  19. Habib GB, Heibig J, Forman SA, et al. Influence of coronary collateral vessels on myocardial infarct size in humans. Circulation 1991;83:739–746.

    Google Scholar 

  20. Lesnefsky EJ, Van Benthuysen KM, McMurtry IF, Shikes RH, Johnston RB Jr., Horwitz LD. Lidocaine reduces canine infarct size and decreases release of a lipid peroxidation product. J Cardiovasc Pharmacol 1989;13:895–901.

    Google Scholar 

  21. Sandler H, Dodge HT. The use of single plane angiocardiograms for the calculation of left ventricular volume in man. Am Heart J 1968;75:325–334.

    Google Scholar 

  22. Sheehan FH, Bolson EL, Dodge HT, Mathey DG, Schofer J, Hok-Wai W. Advantages and applications of the centerline method for characterizing regional ventricular function. Circulation 1986;74:293–305.

    Google Scholar 

  23. Hale SL, Alker KJ, Kloner RA. Evaluation of nonradioactive, colored microspheres for measurement of regional myocardial blood flow in dogs. Circulation 1988;78:428–434.

    Google Scholar 

  24. Cronstein BN, Levin RI, Belanoff J, Weissmann G, Hirschhorn R. Adenosine: An endogenous inhibitor of neutrophil-mediated injury to endothelial cells. J Clin Invest 1986;78:760–770.

    Google Scholar 

  25. Romson JL, Bush LR, Jolly SR, Lucchesi BR. Cardioprotective effects of ibuprofen in experimental regional and global myocardial ischemia. J Cardiovasc Pharmacol 1982;4: 187–196.

    Google Scholar 

  26. Schaer GL, Karas SP, Santoian EC, Gold C, Visner MS, Virmani R. Reduction in reperfusion injury by blood-free reperfusion after experimental myocardial infarction. J Am Coll Cardiol 1990;15:1385–1393.

    Google Scholar 

  27. Vivaldi MT, Kloner RA, Schoen FJ. Triphenyltetrazolium staining of irreversible ischemic injury following coronary artery occlusion in rats. Am J Pathol 1985;121:522–530.

    Google Scholar 

  28. Robinson KA, Hunter RL, Stack JE, Hearn JA, Apkarian RP, Roubin GS. Inhibition of coronary arterial thrombosis in swine by infusion of poloxamer 188. J Invas Cardiol 1990;2:9–20.

    Google Scholar 

  29. Carr ME Jr., Zeker SL, Jones MR. Effects of RheothRx on clot formation in platelet rich plasma (abstr). Blood 1990;76(Suppl. 1):415a.

    Google Scholar 

  30. Kloner RA, Ganote CE, Jennings RB. The “no-reflow” phenomenon after temporary coronary occlusion in the dog. J Clin Invest 1974;54:1496–1508.

    Google Scholar 

  31. Grines CL, Browne KF, Marco J, et al. A comparison of immediate angioplasty with thrombolytic therapy for acute myocardial infarction. N Engl J Med 1993;328:673–679.

    Google Scholar 

  32. Shen YT, Knight DR, Canfield DR, Vatner SF, Thomas JX Jr. Progressive change in collateral blood flow after coronary occlusion in conscious dogs. Am J Physiol 1989;256: H478–H485.

    Google Scholar 

  33. Schwartz H, Leiboff RH, Bren GB, et al. Temporal evolution of the human coronary collateral circulation after myocardial infarction. J Am Coll Cardiol 1984;4:1088–1093.

    Google Scholar 

  34. Rentrop KP, Feit F, Sherman W, Thornton JC. Serial angiographic assessment of coronary artery obstruction and collateral flow in acute myocardial infarction. Report from the second Mount Sinai-New York University reperfusion trial. Circulation 1989;80:1166–1175.

    Google Scholar 

  35. Gallagher KP, Buda AJ, Pace D, Gerren RA, Shlafer M. Failure of superoxide dismutase and catalase to alter size of infarction in conscious dogs after 3 hours of occlusion followed by reperfusion. Circulation 1986;73:1065–1076.

    Google Scholar 

  36. Babbitt DG, Virmani R, Vildibill HD Jr., Norton ED, Forman MB. Intracoronary adenosine administration during reperfusion following 3 hours of ischemia: Effects on infarct size, ventricular function, and regional myocardial blood flow. Am Heart J 1990;120:808–818.

    Google Scholar 

  37. Jolly SR, Kane WJ, Hook BG, Abrams GD, Kunkel SL, Lucchesi BR. Reduction of myocardial infarct size by neutrophil depletion: Effect of duration of occlusion. Am Heart J 1986;112:682–690.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Section of Cardiology, Rush Medical College, Rush University, Rush-Presbyterian-St. Luke’s Medical Center, Chicago, Illinois, USA

    Russel F. Kelly, Tony L. Hursey, Roshni B. Patel, Joseph E. Parrillo & Gary L. Schaer

Authors
  1. Russel F. Kelly
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Tony L. Hursey
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Roshni B. Patel
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Joseph E. Parrillo
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Gary L. Schaer
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Kelly, R.F., Hursey, T.L., Patel, R.B. et al. Effect of Poloxamer 188 on Collateral Blood Flow, Myocardial Infarct Size, and Left Ventricular Function in a Canine Model of Prolonged (3-Hour) Coronary Occlusion and Reperfusion. J Thromb Thrombolysis 5, 239–247 (1998). https://doi.org/10.1023/A:1008848026759

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1008848026759

Search

Navigation